R&D
Business Development
- Categories:R&D
- Time of issue:2020-09-21 10:29:25
- Views:0
Kintor Pharma focuses on developing innovative small molecules and biologic drugs for dermatology and oncology with substantial unmet needs, especially androgen receptor-related diseases. Kintor Pharma's product pipeline consists of seven ongoing clinical products, including androgen receptor antagonists, AR-PROTAC, ALK-1 monoclonal antibody, Hedgehog/SMO inhibitor, mTOR inhibitor and PD-L1/TGF-β dual-targeting antiobdy. The company also has ongoing preclinical programs in ALK-1/VEGF dual-targeting antibody and c-Myc inhibitors. We are actively seeking partnerships for China and worldwide, welcome to contact us!
Tel:+86 512 6263 9916,+86 512 6263 9920
Email:BD@kintor.com.cn
Scan the QR code to read on your phone
Business
News Center
Contact Us
Find Us
Copyright: Kintor Pharmaceutical Limited retains all copyrights. 苏ICP备19028699号-2 Powered by 300.cn
Complaints and Suggestions Tel: +86 512 62639935 Email: public@kintor.com.cn